<DOC>
	<DOCNO>NCT00160342</DOCNO>
	<brief_summary>This research study evaluate effectiveness , safety side effect several dose level esterify estrogen ( EE ) methyltestosterone ( MT ) give individually combination compare placebo ( tablet active drug ) possible treatment vasomotor symptom ( hot flush flush ) menopause . EE testosterone two hormone typically deficient menopausal woman</brief_summary>
	<brief_title>Comparison Estrogen Methyltestosterone Combination Treatments Postmenopausal Hot Flushes</brief_title>
	<detailed_description />
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Estrogens , Esterified ( USP )</mesh_term>
	<mesh_term>Estrone</mesh_term>
	<mesh_term>Methyltestosterone</mesh_term>
	<mesh_term>Testosterone</mesh_term>
	<mesh_term>Testosterone enanthate</mesh_term>
	<mesh_term>Testosterone undecanoate</mesh_term>
	<mesh_term>Testosterone 17 beta-cypionate</mesh_term>
	<criteria>1 . Be able communicate Investigator study staff able complete require study procedure , 2 . Be female race age 4565 year , generally good health , 3 . Be either naturally surgically postmenopausal ( without uterus ) 1 . Known sensitivity contraindication natural synthetic estrogen , androgen progestin , 2 . History current diagnosis malignant melanoma , breast cancer cancer ( except nonmelanomatous skin cancer ) diagnose less 5 year prior begin study</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Hormone replacement therapy , hot flush , postmenopause</keyword>
</DOC>